| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f377cd549cc8329d22085556465393f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91c1fbfe132ea5a6259fb9a4bf901bde |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1858 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
| filingDate |
2001-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea69400f14738810dcd343e82cd8bbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2756f5169d34cda47c944cbbb40cfbed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae3be5c19698233deb6369bec45f857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c81a1a103ec1eeddb11c8718259f2c6c |
| publicationDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1300158-A1 |
| titleOfInvention |
Medicinal compositions for angiogenic therapy |
| abstract |
The present invention provides: (1) pharmaceuticalncompositions for angiogenic therapy which contain, as the activeningredients, at least one substance selected from substances havingnvasodilating effect and/or platelet aggregation inhibitory effect,nand substances producing them; and a gene encoding an angiogenesisnfactor; (2) agents for potentiating the angiogenic effect of a genenencoding an angiogenesis factor that contain, as the active ingredient,nat least one substance selected from substances having vasodilatingneffect and/or platelet aggregation inhibitory effect and substancesnproducing them; (3) an angiogenic agent which contains a prostacyclinnsynthase gene as the active ingredient; (4) pharmaceuticalncompositions for angiogenic therapy which contain ets-1 gene andnanother gene encoding an angiogenesis factor as the activeningredients; (4) an agent which contain ets-1 gene as the activeningredient for potentiating the angiogenic effect of another genenencoding an angiogenesis factor; and (5) an angiogenic agent whichncontains ets-1 gene as the active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2474325-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2474325-A1 |
| priorityDate |
2000-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |